Inflazyme Pharmaceuticals (T.IZP) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Inflazyme Pharmaceuticals (T.IZP)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Sean Janzen who wrote (1247)	6/2/1999 5:09:00 PM
From: David Graham	Read Replies (1) of 1501

For those who are interested, Neil Meadel's Mini-Cap Analyst newsletter has recommended selling IZP (although I think many Meadel readers bailed a long time ago). For those who aren't familiar with the newsletter, it initially recommended IZP in March 1996 at C$0.81 and suggested buying more in December 1998 at C$0.55. Meadel believes that there has just been too much dilution in the last month to generate spectacular prices increases any time soon and that profits should be taken now. He says "the worst thing is that we cannot anticipate major share-price-boosting news until the first half of next year". The increase in market cap "has been achieved via a full-scale share hemorrhage". Currently the f/d share position is approx 50 million without factoring in the conversion of HMR's convertibles. IMHO - Not to mention that technically the stock has loads of resistance pretty much from $2.25 to $3.25. David

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next